Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Metabolism & Toxicology|May 29, 2012
Organotypic systems in drug metabolism and toxicity: challenges and opportunitiesAjit Dash, Brett R Blackman, Brian R Wamhoff
Expert Opinion on Drug Discovery|December 1, 2017
Non-alcoholic fatty liver disease (NAFLD) models in drug discoveryBanumathi K Cole, Ryan E Feaver, Brian R Wamhoff, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 21, 2016
Drug-induced steatohepatitisAjit Dash, Robert A Figler, Arun J Sanyal, et al.
Photochemistry and Photobiology|October 10, 2013
One-Pot Fabrication of RGO-Ag3 VO4 Nanocomposites by in situ Photoreduction using Different Sacrificial Agents: High Selectivity Toward Catechol Synthesis and Photodegradation AbilityDipti P Das, Alaka Samal, Jasobanta Das, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 12, 2024
Simulation-based evaluation of personalized dosing approaches for anti-FGFR/KLB bispecific antibody fazpilodemabKenta Yoshida, Victor Poon, Ajit Dash, et al.
Lab on a Chip|December 22, 2009
Perfused multiwell plate for 3D liver tissue engineeringKarel Domansky, Walker Inman, James Serdy, et al.
Chemical Research in Toxicology|February 6, 2010
Proteins modified by the lipid peroxidation aldehyde 9,12-dioxo-10(E)-dodecenoic acid in MCF7 breast cancer cellsPeter G Slade, Michelle V Williams, Viral Brahmbhatt, et al.
Advances in Cancer Research|April 11, 2007
Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progressionClayton Yates, Chistopher R Shepard, Glenn Papworth, et al.
Hepatology (Baltimore, Md.)|August 22, 2022
Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trialChin Wong, Ajit Dash, Jill Fredrickson, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 30, 2009
Liver tissue engineering in the evaluation of drug safetyAjit Dash, Walker Inman, Keith Hoffmaster, et al.
Pageof 3